FDA cleared the Lilium one (USM330) from Lilium Otsuka Co., Ltd. on Oct 16, 2026 under K260605, a traditional 510(k) reviewed through the Third Party Review Program. The device falls under product code IYO, System, Imaging, Pulsed Echo, Ultrasonic, regulated at 21 CFR 892.1560 as a Class 2 device. The review panel was Radiology.
FDA logged the submission as received on Feb 24, 2026. The decision came 234 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
This is the only decision on file for Lilium Otsuka Co., Ltd. in the last 12 months of the tracker.